Aymerich MS

References (3)

Title : Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease - Ayerra_2025_Brain.Behav.Immun__
Author(s) : Ayerra L , Abellanas MA , Vidaurre C , Basurco L , Tavira A , Luquin E , Clavero P , Mengual E , Collantes M , Penuelas I , de Martin-Esteban SR , Grether U , Hillard CJ , Romero J , Hervas-Stubbs S , Aymerich MS
Ref : Brain Behavior & Immunity , : , 2025
Abstract :
PubMedSearch : Ayerra_2025_Brain.Behav.Immun__
PubMedID: 40320016

Title : CB2 Receptors and Neuron-Glia Interactions Modulate Neurotoxicity Generated by MAGL Inhibition - Rojo-Bustamante_2020_Biomolecules_10_
Author(s) : Rojo-Bustamante E , nigo-Marco I , Abellanas MA , Vinueza-Gavilanes R , Baltanas A , Luquin E , Arrasate M , Aymerich MS
Ref : Biomolecules , 10 : , 2020
Abstract :
PubMedSearch : Rojo-Bustamante_2020_Biomolecules_10_
PubMedID: 32824740

Title : Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model - Fernandez-Suarez_2014_Neurobiol.Aging_35_2603
Author(s) : Fernandez-Suarez D , Celorrio M , Riezu-Boj JI , Ugarte A , Pacheco R , Gonzalez H , Oyarzabal J , Hillard CJ , Franco R , Aymerich MS
Ref : Neurobiology of Aging , 35 :2603 , 2014
Abstract :
PubMedSearch : Fernandez-Suarez_2014_Neurobiol.Aging_35_2603
PubMedID: 24973119